194 related articles for article (PubMed ID: 33902034)
1. Measuring and Modelling the Epithelial- Mesenchymal Hybrid State in Cancer: Clinical Implications.
Jolly MK; Murphy RJ; Bhatia S; Whitfield HJ; Redfern A; Davis MJ; Thompson EW
Cells Tissues Organs; 2022; 211(2):110-133. PubMed ID: 33902034
[TBL] [Abstract][Full Text] [Related]
2. Emerging Concepts of Hybrid Epithelial-to-Mesenchymal Transition in Cancer Progression.
Sinha D; Saha P; Samanta A; Bishayee A
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33207810
[TBL] [Abstract][Full Text] [Related]
3. The epithelial-mesenchymal plasticity landscape: principles of design and mechanisms of regulation.
Haerinck J; Goossens S; Berx G
Nat Rev Genet; 2023 Sep; 24(9):590-609. PubMed ID: 37169858
[TBL] [Abstract][Full Text] [Related]
4. Emerging roles of epithelial-mesenchymal plasticity in invasion-metastasis cascade and therapy resistance.
Garg M
Cancer Metastasis Rev; 2022 Mar; 41(1):131-145. PubMed ID: 34978017
[TBL] [Abstract][Full Text] [Related]
5. A Computational Systems Biology Approach Identifies SLUG as a Mediator of Partial Epithelial-Mesenchymal Transition (EMT).
Subbalakshmi AR; Sahoo S; Biswas K; Jolly MK
Cells Tissues Organs; 2022; 211(6):689-702. PubMed ID: 33567424
[TBL] [Abstract][Full Text] [Related]
6. Targeting epithelial-mesenchymal plasticity in cancer: clinical and preclinical advances in therapy and monitoring.
Bhatia S; Monkman J; Toh AKL; Nagaraj SH; Thompson EW
Biochem J; 2017 Sep; 474(19):3269-3306. PubMed ID: 28931648
[TBL] [Abstract][Full Text] [Related]
7. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.
Jolly MK; Somarelli JA; Sheth M; Biddle A; Tripathi SC; Armstrong AJ; Hanash SM; Bapat SA; Rangarajan A; Levine H
Pharmacol Ther; 2019 Feb; 194():161-184. PubMed ID: 30268772
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of hybrid epithelial-mesenchymal cell states in cancer.
Sample RA; Nogueira MF; Mitra RD; Puram SV
Oncogene; 2023 Jul; 42(29):2237-2248. PubMed ID: 37344626
[TBL] [Abstract][Full Text] [Related]
9. Hybrid Epithelial/Mesenchymal State in Cancer Metastasis: Clinical Significance and Regulatory Mechanisms.
Liao TT; Yang MH
Cells; 2020 Mar; 9(3):. PubMed ID: 32143517
[TBL] [Abstract][Full Text] [Related]
10. Stability of the hybrid epithelial/mesenchymal phenotype.
Jolly MK; Tripathi SC; Jia D; Mooney SM; Celiktas M; Hanash SM; Mani SA; Pienta KJ; Ben-Jacob E; Levine H
Oncotarget; 2016 May; 7(19):27067-84. PubMed ID: 27008704
[TBL] [Abstract][Full Text] [Related]
11. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
Garg M
Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
[TBL] [Abstract][Full Text] [Related]
12. A specialist-generalist framework for epithelial-mesenchymal plasticity in cancer.
Cook DP; Wrana JL
Trends Cancer; 2022 May; 8(5):358-368. PubMed ID: 35183479
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of Epithelial-Mesenchymal Plasticity: What Have Single-Cell Investigations Elucidated So Far?
Subhadarshini S; Markus J; Sahoo S; Jolly MK
ACS Omega; 2023 Apr; 8(13):11665-11673. PubMed ID: 37033874
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-Mesenchymal Plasticity in Tumor Immune Evasion.
Mullins RDZ; Pal A; Barrett TF; Heft Neal ME; Puram SV
Cancer Res; 2022 Jul; 82(13):2329-2343. PubMed ID: 35363853
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomic-Based Quantification of the Epithelial-Hybrid-Mesenchymal Spectrum across Biological Contexts.
Mandal S; Tejaswi T; Janivara R; Srikrishnan S; Thakur P; Sahoo S; Chakraborty P; Sohal SS; Levine H; George JT; Jolly MK
Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053177
[TBL] [Abstract][Full Text] [Related]
16. Network topology metrics explaining enrichment of hybrid epithelial/mesenchymal phenotypes in metastasis.
Rashid M; Hari K; Thampi J; Santhosh NK; Jolly MK
PLoS Comput Biol; 2022 Nov; 18(11):e1010687. PubMed ID: 36346808
[TBL] [Abstract][Full Text] [Related]
17. Controversies around epithelial-mesenchymal plasticity in cancer metastasis.
Williams ED; Gao D; Redfern A; Thompson EW
Nat Rev Cancer; 2019 Dec; 19(12):716-732. PubMed ID: 31666716
[TBL] [Abstract][Full Text] [Related]
18. Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells.
Kröger C; Afeyan A; Mraz J; Eaton EN; Reinhardt F; Khodor YL; Thiru P; Bierie B; Ye X; Burge CB; Weinberg RA
Proc Natl Acad Sci U S A; 2019 Apr; 116(15):7353-7362. PubMed ID: 30910979
[TBL] [Abstract][Full Text] [Related]
19. Hybrid Epithelial-Mesenchymal Phenotypes Are Controlled by Microenvironmental Factors.
Selvaggio G; Canato S; Pawar A; Monteiro PT; Guerreiro PS; Brás MM; Janody F; Chaouiya C
Cancer Res; 2020 Jun; 80(11):2407-2420. PubMed ID: 32217696
[TBL] [Abstract][Full Text] [Related]
20. Human-specific RNA analysis shows uncoupled epithelial-mesenchymal plasticity in circulating and disseminated tumour cells from human breast cancer xenografts.
Tachtsidis A; Le AV; Blick T; Gunasinghe D; De Sousa E; Waltham M; Dobrovic A; Thompson EW
Clin Exp Metastasis; 2019 Aug; 36(4):393-409. PubMed ID: 31190270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
